Skip to Navigation
Skip to Main Content
Skip to Related Content

Advertisement

U.S. Markets close in 1 hr 25 mins

S&P 500
5,781.02
-70.18(-1.20%)
Dow 30
42,425.02
-499.87(-1.16%)
Nasdaq
18,211.77
-361.36(-1.95%)
Russell 2000
2,195.50
-36.03(-1.61%)
Crude Oil
70.87
-0.87(-1.21%)
Gold
2,727.40
-32.40(-1.17%)

Abrdn Healthcare Investors (HQH)

NYSE - Nasdaq Real Time Price. Currency in USD

Follow

Visitors trend2W10W9M

18.36

-0.21

(-1.13%)

As of 02:35PM EDT. Market open.

Currency in USD

Valuation Measures⁴

Market Cap (intraday)	940.61M
Enterprise Value	N/A
Trailing P/E	14.18
Forward P/E	N/A
PEG Ratio (5 yr expected)	N/A
Price/Sales (ttm)	13.25
Price/Book (mrq)	0.93
Enterprise Value/Revenue	12.62
Enterprise Value/EBITDA	N/A

Trading Information

Stock Price History

Beta (5Y Monthly)	0.74
52-Week Change ³	N/A
S&P500 52-Week Change ³	N/A
52 Week High ³	19.79
52 Week Low ³	14.31
50-Day Moving Average ³	18.78
200-Day Moving Average ³	17.56

Share Statistics

Avg Vol (3 month) ³	141.63k
Avg Vol (10 day) ³	107.88k
Shares Outstanding ⁵	50.62M
Implied Shares Outstanding ⁶	N/A
Float ⁸	N/A
% Held by Insiders ¹	0.01%
% Held by Institutions ¹	29.02%
Shares Short (Sep 30, 2024) ⁴	106.9k
Short Ratio (Sep 30, 2024) ⁴	1
Short % of Float (Sep 30, 2024) ⁴	N/A
Short % of Shares Outstanding (Sep 30, 2024) ⁴	0.21%
Shares Short (prior month Aug 30, 2024) ⁴	197.82k

Dividends & Splits

Forward Annual Dividend Rate ⁴	2.04
Forward Annual Dividend Yield ⁴	10.98%
Trailing Annual Dividend Rate ³	1.66
Trailing Annual Dividend Yield ³	8.94%
5 Year Average Dividend Yield ⁴	9.19
Payout Ratio ⁴	126.72%
Dividend Date ³	Dec 31, 2018
Ex-Dividend Date ⁴	Aug 23, 2024
Last Split Factor ²	N/A
Last Split Date ³	N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends	Sep 30, 2023
Most Recent Quarter (mrq)	Mar 31, 2024

Profitability

Profit Margin	730.94%
Operating Margin (ttm)	-0.59%

Management Effectiveness

Return on Assets (ttm)	-0.07%
Return on Equity (ttm)	7.33%

Income Statement

Revenue (ttm)	9.97M
Revenue Per Share (ttm)	0.20
Quarterly Revenue Growth (yoy)	-5.70%
Gross Profit (ttm)	N/A
EBITDA	N/A
Net Income Avi to Common (ttm)	72.87M
Diluted EPS (ttm)	1.31
Quarterly Earnings Growth (yoy)	19.90%

Balance Sheet

Total Cash (mrq)	14.1k
Total Cash Per Share (mrq)	0
Total Debt (mrq)	N/A
Total Debt/Equity (mrq)	N/A
Current Ratio (mrq)	0.47
Book Value Per Share (mrq)	19.91

Cash Flow Statement

Operating Cash Flow (ttm)	N/A
Levered Free Cash Flow (ttm)	N/A